#MonogramHealth is proud to work with distinguished physician organizations who play a pivotal role in accelerating our mission to expand access to best-in-class, in-home care for individuals with #CKD, #ESKD and other chronic conditions. Learn more about how we collaborate with providers to deliver a full suite of high-quality care management services that improve patient outcomes and reduce clinical burden. #KidneyHealth #ValueBasedCare #EvidenceBasedCare #InHomeCare #PrimaryCare #SpecialtyCare #PolychronicCare #PolychronicConditions #Polychronic
Monogram Health’s Post
More Relevant Posts
-
We believe in empowering you to take control of your health. We offer access to innovative new treatments and diagnostic tests through clinical trials, all while prioritizing your well-being and comfort. By participating in clinical trials you contribute to the development of groundbreaking treatments that can improve the lives of countless individuals. Ready to Join the Movement? Call ☎️ (972) 216-5100 to explore our ongoing clinical trials covering a wide range of health conditions. #DFWHealth #BeTheChange #YourHealthMatters #Mesquite #SMSClinicalResearch #HealthyLiving #ClinicalTrial #PatientCare #MedicalResearch #ClinicalTrials #Covid19 #HealthScience #ClinicalStudy #ResearchTrial #PatientCare #HealthCare #LungCancer #UrinaryTractInfection #Treatment #Eczema #RSVTreatment #Psoriasis
To view or add a comment, sign in
-
Dr. Mihir M. Kamdar, MD presents key findings from our recent randomized controlled trial of ePAL, a cutting-edge digital app developed to improve care for patients with serious illness. The trial revealed that patients using ePAL experienced a 26% reduction in pain and nearly 70% fewer hospital admissions due to pain—a major advancement in managing serious illness. This technology demonstrates the power of continuous monitoring in reducing suffering and healthcare costs. 📉 In the video, Dr. Kamdar also introduces our next step: the MyTuesday platform, which broadens the scope beyond oncology to address a variety of symptoms across different serious illnesses, aiming to enhance symptom management and reduce hospitalizations. 📺 Watch the video to see how we’re revolutionizing patient care and learn more about how MyTuesday is set to make a significant impact. 🔗 Watch Now: https://lnkd.in/gveENtsA #TuesdayHealth #ePAL #MyTuesday #PalliativeCare #DigitalHealth #HealthcareInnovation #PatientCare
To view or add a comment, sign in
-
Our impact🎯 * Reducing reliance on the overburdened healthcare system through POC testing. * Decreasing the time and cost of care related to chronic kidney disease. * Improving the quality of life for people with acute and chronic kidney disease. * Increasing access to progressive clinical drugs and treatments while reducing the costs and time of clinical trials. * Providing accessible and affordable healthcare. * Identifying and staging kidney diseases through our innovative POC Testing platform. * Offering comprehensive patient management solutions. * Enhancing efficiency for clinicians. We're excited about the positive impact our initiatives are having on healthcare delivery and patient outcomes! #health #healthcare #ckd #poc #pointofcaretesting #chronicdisease #kidneydisease
To view or add a comment, sign in
-
This study suggests a significant discrepancy in how patients and healthcare professionals define remission for #IBD, which could affect patient expectations and clinical outcomes. #Patients often view remission as relief from symptoms, whereas health care professionals emphasize objective measures like endoscopic or histologic remission. #inflammatoryboweldisease Crohn's and Colitis Canada | Crohn et Colite Canada Crohn's & Colitis Foundation Crohn's & Colitis UK Crohn’s & Colitis Australia https://lnkd.in/ghc_u7Eu
To view or add a comment, sign in
-
Discover unparalleled evidence with B·R·A·H·M·S PCT™! A patient-level meta-analysis provides compelling evidence that B·R·A·H·M·S PCT-aided ABS has a similar impact on antibiotic exposure and mortality in geriatric patients as it does in younger adults. Trust in B·R·A·H·M·S PCT for optimizing healthcare outcomes. https://lnkd.in/gd_SPJYN #thermofisheremp
To view or add a comment, sign in
-
Discover unparalleled evidence with B·R·A·H·M·S PCT™! A patient-level meta-analysis provides compelling evidence that B·R·A·H·M·S PCT-aided ABS has a similar impact on antibiotic exposure and mortality in geriatric patients as it does in younger adults. Trust in B·R·A·H·M·S PCT for optimizing healthcare outcomes. https://lnkd.in/d3j2Jca3 #thermofisheremp
To view or add a comment, sign in
-
Discover unparalleled evidence with B·R·A·H·M·S PCT™! A patient-level meta-analysis provides compelling evidence that B·R·A·H·M·S PCT-aided ABS has a similar impact on antibiotic exposure and mortality in geriatric patients as it does in younger adults. Trust in B·R·A·H·M·S PCT for optimizing healthcare outcomes. https://lnkd.in/ephfhF4n #thermofisheremp
To view or add a comment, sign in
-
Discover unparalleled evidence with B·R·A·H·M·S PCT™! A patient-level meta-analysis provides compelling evidence that B·R·A·H·M·S PCT-aided ABS has a similar impact on antibiotic exposure and mortality in geriatric patients as it does in younger adults. Trust in B·R·A·H·M·S PCT for optimizing healthcare outcomes. https://lnkd.in/d5Vtxz3U #thermofisheremp
To view or add a comment, sign in
-
RARE DISEASE CASE STUDY: A #lifesciences organization was interested in characterizing and quantifying the total burden of a #raredisease for patients, caregivers, and US society at large. They asked #AvalereExperts to research the full range of medical and nonmedical costs associated with the disease. Read the full case study: https://lnkd.in/eUxdCqG6 📚 Interested in diving deeper on #rarediseases? Download our free eBook on the policy, market access, and evidence landscape of rare disease in the United States and globally: https://lnkd.in/eeE_zyvk #healthpolicy #marketaccess #evidencegeneration #healthcare #rarediseases
To view or add a comment, sign in
-
Help us uncover the factors fueling this disease. Sign up for our clinical trial today. See if you qualify today! https://lnkd.in/gan_P5dx You may qualify to receive up to $2,000-$3,000 compensation upon enrollment in one of our Clinical Trials. #ibdawareness #ibdwarrior #crohns #crohnsdisease #ulcerativecolitis #colitis #chronicillness #clinicaltrial #healthresearch #patientadvocacy #patientcare #clinicalresearch #researchstudy #medicalresearch #patientexperience #patientempowerment #healthcare #healthylifestyle #healthandwellness #medicaladvancements #medicalbreakthrough #fightibd #beatcrohns #stopcolitis #chronsdiseaseawareness #colitisawareness #clinicaltrialparticipation #researchparticipants #healthresearcher #healthscience
To view or add a comment, sign in
15,956 followers